Your Health. Your Family. Your Choice.
Administered by: Other Purchased by: ?
Life Threatening? No
Write-up: Death unexplained; Oxygen saturation decreased; This is a spontaneous report from a contactable physician downloaded from the Medicines Agency (MA) regulatory authority-WEB FR-AFSSAPS-MA20210320. A 93-year-old female patient received first dose of bnt162b2 (COMIRNATY) (lot/batch number EJ6788), intramuscular on 28Jan2021 at SINGLE DOSE for covid-19 immunization. Medical history included cardiac failure/heart failure from an unknown date and unknown if ongoing, rhythm disturbances, bio-mitral prosthesis, left breast cancer, hypertension. Patient considered to be at risk of developing a severe form of COVID-19. Patient who did not have COVID-19. Concomitant medications included apixaban, oxazepam (SERESTA), paracetamol, mirtazepam. The patient experienced death unexplained on 02Feb2021, oxygen saturation decreased (death) on 29Jan2021. Appearance of a 74% in O2 desaturation with rapid degradation of the patient during the weekend of 30-31Jan. Unconfirmed suspicion of COVID-19 (no PCR performed). The patient died on 02Feb2021. It was not reported if an autopsy was performed. No follow-up attempts are possible. No further information is expected.; Reported Cause(s) of Death: Death unexplained; Oxygen saturation decreased
Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166